A Study to Evaluate Radiation Dermatitis Severity in Irradiated Skin protected By An Agent Versus Uncovered Skin

Overview

About this study

The purpose of this study is to compare radiation dermatitis severity in irradiated skin protected by an agent versus uncovered skin (internal control) based on photographs.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Age ≥ 18 years.
  •  Undergoing external beam radiotherapy for head/neck cancer at Mayo Clinic Rochester campus.
  • Note: patients undergoing concurrent chemotherapy are eligible.
  • Able to provide informed written consent.
  • Willing to consent for photography of radiation field.
  • Receiving a dose ³ 45 Gy and 20 fractions to both the area being treated and the area being used for comparison.

Exclusion Criteria: 

  • Patients with active rash, pre-existing dermatitis, lupus, tattoos,scleroderma or other conditions within the treatment area that may make skin assessment for the study difficult per treating physician discretion.
  • Patients with known allergic and other systemic skin diseases even if not directly affecting irradiated fields.
  • Any medical condition that in the opinion of the investigator should exclude him/her from participating in the study.
  • Enrolled in an investigational study where product was applied to the proposed study site within 30 days of the screening visit.
  • The skin area affected by radiation requires treatment with a concomitant medication or product (if applicable).

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Ivy Petersen, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available
.
CLS-20502002

Mayo Clinic Footer